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Abstract.  The MB1 regulatory sequence of the myelin 
basic protein (MBP) gene spanning between nucle- 
otides -14 to -50 with respect to the transcription start 
site is critical for cell type-specific transcription of the 
MBP gene, which encodes the major protein compo- 
nent of myelin sheath in cells derived from the central 
nervous system (CNS). This regulatory sequence has 
the ability to interact with a developmentally controlled 
DNA-binding protein from mouse brain that stimulates 
transcription of MBP promoter in an in vitro system 
(Haas, S., J. Gordon, and K. Khalili. 1993. Mol.  Cell. 
Biol. 13:3103-3112). Here, we report the purification of 
a 39-kD protein from mouse brain tissue at the peak of 
myelination and MBP production that binds to the 
MB1 regulatory motif. Following partial amino acid se- 
quence analysis, we have identified a complementary 
DNA encoding a 39-kD DNA-binding protein called 
pur a. Expression ofpur  a  cDNA in the prokaryotic 
and eukaryotic cells resulted in the synthesis of a pro- 
tein with characteristics similar to the purified brain- 
derived 39-kD protein in band shift competition assays. 
Cotransfection of the recombinant pur ~  expressor 
plasmid with MBP promoter construct indicated that 
Pur t~ stimulates transcription of the MBP promoter in 
oligodendrocytic cells, and that the nucleotide se- 
quence required for binding of the 39-kD Pur c~ to 
DNA within the MB1 region is crucial for this activity. 
Moreover, transient expression of Pur a  caused eleva- 
tion in the level of endogenous MBP RNA in oligoden- 
drocytic cells. Thus, Pur or, a sequence-specific DNA- 
binding protein upon binding to MB 1 regulatory region 
may play a significant role in determining the cell type- 
specific expression of MBP in brain. 
M 
YELIN basic protein (MBP) 1 is  a  major compo- 
nent  of the  myelin  sheath  composing  greater 
than 30% of the total myelin protein in the cen- 
tral nervous system (CNS) (6, for review see 5). This pro- 
tein has several isoforms, all of which are encoded by al- 
ternative splicing of a single major transcript from a single 
gene on mouse chromosome 18 (7, 23, 33, 35, 36, 43). MBP 
is  expressed in  a  cell type-specific manner.  In  the  CNS, 
myelin formation and MBP gene expression occur in oli- 
godendrocytes, whereas in the peripheral nervous system 
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(PNS), Schwann cells are responsible for myelin formation 
and expression of the MBP gene (31). The cell type and 
developmental  expression  of  myelin  basic  protein  has 
been demonstrated to be regulated at the level of tran- 
scription (6, 10, 47). Initial transgenic studies using a trans- 
gene that contained the entire MBP genomic locus includ- 
ing all introns and exons, as well as 4 kb of the 5' flanking 
sequence and 3 kb of the 3' flanking sequence revealed re- 
stricted  expression  of  the  transgene  in  brain  with  the 
proper developmental pattern (34). In subsequent studies, 
as  little as  1.3  kb  of the  MBP 5'  flanking sequence has 
been shown to direct specific and developmentally regu- 
lated expression of the MBP cDNA-coding sequence (24) 
or a heterologous reporter gene (t2, 14, 28). In addition, 
transient  transfection  and  in  vitro  transcription  studies 
have been used by several laboratories including ours to 
identify regulatory sequences that may participate in the 
restricted expression of the MBP gene (8, 9, 29, 44). These 
studies have indicated that the MBP regulatory region is 
composed of multiple cis-acting elements, some of which 
stimulate transcription of the reporter gene in CNS-derived 
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quence  from nucleotides  -14 to  -50 bp (relative to the 
RNA start site at  +1  bp) and has been shown to direct 
glial cell type specific expression of a  heterologous  pro- 
moter. Due to its position directly upstream of the tran- 
scription start site, the MB1 element was initially thought 
to be involved in a direct interaction with TATA box bind- 
ing protein and serve as a core promoter element for the 
assembly of the preinitiation complex. Sequence  analysis 
of this region, however, indicated  that the MB1  element 
lacks a typical TATA box, and further, in vitro transcrip- 
tion  studies  suggest  that  this  TATA  box-like  sequence 
(TTCAAA) is not responsible for tissue-specific transcrip- 
tion of the MBP proximal promoter (45). The distal regu- 
latory element of the MBP promoter between nucleotides 
-93 to -209 contains multiple positive and negative regu- 
latory elements including a binding site for the nuclear fac- 
tor 1 (NF-I) family of transcription factors (21), and differ- 
entially  regulates  MBP  promoter  activities  in  glial  and 
non-glial cells. Previous studies from our laboratory indi- 
cated  that  the  proximal  MB1  regulatory  region  has  the 
ability to interact with a 38--41-kD protein from crude nu- 
clear extract derived from mouse brain tissue and stimu- 
lates transcription of the MBP promoter in an in vitro sys- 
tem (18).  Of particular interest  was the observation that 
the 38-41-kD MBl-associated proteins are expressed in a 
tissue-specific  and  developmental  stage-specific  pattern 
that overlaps with the pattern of MBP transcription in the 
developing mouse. 
In this study,  we have purified  a  39-kD, MBl-binding 
protein from mouse brain at the  peak of myelination to 
homogeneity, identified a cDNA with the potential for en- 
coding the 39-kD protein, and evaluated its ability to stim- 
ulate  transcription  of  the  exogenous  and  endogenous 
MBP promoter in oligodendrocytic cells. 
Materials and Methods 
Nuclear Extract Preparation 
Mice  were  obtained  from a  commercial vendor  (Jackson  ImmunoRe- 
search Labs., Inc., West Grove, PA) or from the Jefferson Cancer Insti- 
tute transgenic facility (kindly provided by Dr. L. Siracusa, Jefferson Can- 
cer Institute), and mouse brain tissue was stored at  -80°C before use. 
Nuclear extracts were prepared from mouse brain tissue essentially by the 
method of Ahmed et al. (1). Omission of the final step, concentration of 
the protein sample by precipitation with ammonium sulfate (0.33  g/ml), 
was found to increase the yield of subsequent chromatography. 
Protein Purification 
PhosphoceUulose Chromatography. Phosphocellulose  slurry,  200  ml,  was 
freshly packed in a 2.5  x  15-cm column (Bio-Rad Labs., Richmond, CA) 
to give ~90 ml packed bed volume and equilibrated with five volumes 
(~500 ml) buffer D10o containing 10 mM Hepes (pH 7.9), 1.5 mM MgC12, 
100  mM KC1, 0.5  mM DTF, 0.5  mM PMSF,  and  10%  glycerol, before 
loading. Nuclear extract was diluted with buffer Do (D100 without KC1) to 
a  final salt concentration of -<100  raM,  as determined by conductivity 
measurement, and loaded by gravity flow. The column was washed with 
buffer Du~ until OD260 of the eluate reached baseline, and was eluted with 
a linear salt gradient of buffer D (400 ml total volume) containing 100-800 
mM KC1. Fractions containing MBl-binding activity were identified by 
quantitative band shift assay. 
Preparation  of DNA Affinity Gels and Chromatography.  DNA affinity sup- 
ports were prepared essentially according to the method of Kadonaga and 
Tjian (22). Cyanogen bromide activated sepharose (Pharmacia), 1.5 g, was 
swelled in 20 ml 1 mM HCI and washed with 300 ml 1 mM HC1 on a sin- 
tered glass funnel. The gel was immediately resuspended in 7.5 ml cou- 
pling buffer (0.1  M  Na-phosphate, pH 8.0;  0.5  M  NaC1)  containing the 
DNA ligands and incubated overnight at room temperature with gentle 
rocking. Single-stranded oligodeoxynucleotides were purified by prepara- 
tive gel electrophoresis before coupling. Following coupling, excess reac- 
tive groups in the gel were blocked by incubation of the gel in 1.0 M etha- 
nolamine  (pH  8.3)  for  6  h  at  room  temperature  with  gentle  rocking. 
Uncoupled DNA was removed from the gel by washing with three cycles 
of buffer E1 containing 0.1 M HOAc (pH 4.0) and 0.5 M NaCI, and buffer 
E2 containing 0.1 M Na-phosphate (pH 8.3) and 0.5 M NaC1. The coupling 
efficiency was monitored by incorporation of radioactivity into the gel, 
and was typically 10-30% for double-stranded DNA and 1-3% for single- 
stranded DNA. 
DNA affinity gels were packed in a  1.5 ×  5-cm column (Bio Rad) re- 
suiting in a  packed bed volume of 4-5 ml. DNA affinity columns were 
washed with two cycles of buffer E1 and E2 before each use, then equili- 
brated with 10 bed volumes (~50 ml) of buffer Xls{} containing 12 mM 
Hepes (pH 7.9), 5 mM MgCI2, 150 mM KC1, 0.5 mM DTT, and 10% glyc- 
erol  before loading. Protein samples were diluted with buffer X0 (X150 
without KCI) to a final salt concentration of -<150 mM, as determined by 
conductivity measurement, and loaded by gravity flow. The column was 
washed with excessive (at least 40 ml) buffer X150 until the OD260 of the 
cluate reached baseline, and proteins were eluted by washing the column 
sequentially with 20 ml buffer Xs00 (X150 except containing 0.5  M  KCI) 
then 20 ml buffer X1000 (X150 except containing 1.0 M KCI). Fractions con- 
taining MBl-binding activity were identified by quantitative band shift as- 
say. DNA affinity gels were reused as many as 30 times with no apparent 
loss of their binding capacity. 
For concentrating the active fractions, pooled fractions were dialyzed 
overnight against three changes, 50 volumes each, of a buffer containing 5 
mM Hepes (pH 7.9), 10 mM NaCI, 1 mM MgCI2, and 0.5 mM DTT. Dialy- 
sis served to remove salt and glycerol from column fractions following 
chromatography. Samples were concentrated by centrifugation under vac- 
uum (Speedvac) to 20% of their original volume. Concentration to lesser 
volumes resulted in increased sample viscosity and poor electrophoretic 
mobility of samples, presumably due to incomplete dialysis before concen- 
tration. 
For  amino acid  analysis, second  pass  affinity-purified MBl-binding 
protein, 25 pmol as estimated by quantitative gel shift assay, was concen- 
trated, resolved on SDS-10% PAGE, and transferred to polyvinylidine di- 
fluoride  (PVDF)  membrane  (Immobilon-P;  Millipore  Corp.,  Bedford, 
MA) in a buffer containing 25 mM Tris (pH 7.8), 192 mM glycine and 15% 
methanol according to the manufacturer's instructions. Following trans- 
fer, the blot was stained for 15 min in 45%  methanol/10% HOAc/0.1% 
Coomassie brilliant blue, and destained twice, 10 min each, in 45 % metha- 
nol/7% HOAc. Bands corresponding to the 37- and 39-kD proteins were 
excised from the blot, washed five times in HPLC-grade water (1 ml per 
wash)  with  extensive  vortexing,  and  dried  completely  under  vacuum 
(Speedvac).  Samples were  sent to  Dr.  W.  Lane  (Harvard  Microchem, 
Cambridge, MA) for quantitation by amino acid analysis. Amino acid se- 
quencing of the 39-kD MBl-binding protein was done according to the 
procedure described previously (20). 
Quantitative Band Shift Assay 
Band shift assays were performed essentially as previously described (18) 
except that poly dI-dC was omitted to obtain maximal binding. Specific 
activity of the single-stranded MB1 end-labeled probe was determined by 
precipitation with trichloroacetic acid (2) and was generally 0.5-2.0 ×  10  ~ 
cpm/txg). Complexes were detected by autoradiography of the dried gels, 
and the bands were excised from the gels and quantitated by liquid scintil- 
lation counting. The amount of protein present in each band was calcu- 
lated based on the assumption of 1:1 stoichiometry of protein/DNA in the 
complex. 
Prokaryotic Expression of  pur a 
Plasmid pMAL-pur  a  was generated by insertion of 1.14-kb EcoRI  re- 
striction fragment ofpur a cDNA into the EcoRI site of pMAL-cRI (New 
England  Biolabs,  Boston,  MA).  E.  coli  containing  pMAL-pur  a  or 
pMAL-cRI control plasmid were grown usually in a 500-ml culture, total 
bacterial  proteins were  collected  and  fusion proteins were  purified  by 
amylose affinity chromatography according to the manufacturer's instruc- 
tions (New England Biolabs). For band shift assay, ~2 ×  104 cpm of the 
32p-end-labeled single-stranded MB1 was incubated with 5 Izg of maltose- 
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previously (18), and the complexes were analyzed on a native 9% PAGE. 
Eukaryotic Expression  of  pur a 
Pur a  cDNA (1.14-kb EcoRI  fragment) was placed downstream of the 
CMV  promoter in the pcDNA3 expression vector  (Stratagene  Inc., La 
Jolla, CA). For put cL expression in eukaryotic cells, 30 I~g of the plasmid 
DNA was introduced into the N20.1, an oligodendrocytic cell line condi- 
tionally immortalized with a retroviral vector bearing a thermolabile SV-40 
T-antigen (46).  This cell line expresses MBP and PLP messages in addi- 
tion to the early oligodendrocyte marker 2',3'-cyclic nucleotide 3'-phos- 
phodiesterase mRNA. 48 h  after transfection, cells were harvested and 
nuclear proteins were prepared and used in band shift and competition ex- 
periments by the procedure described previously (18). 
Site-directed Mutagenesis 
The DNA fragment encompassing nucleotide  -86 relative to the tran- 
scription start site to  +21  bp downstream of the transcription initiation 
site of mouse MBP that was cloned in the M13 phage DNA was used for 
site-directed mutagenesis in the MB1 region. The mutation was designed 
to reduce the binding of the 39-kD protein within the MB1 region (see 
Fig. 1 C, oligo MB1A*). The detail strategy for site-directed mutagenesis, 
and selection of the mutants by growing the transformed cells in uridine 
containing medium is described previously (2).  Once the mutants were 
identified, double-stranded phage DNA containing the mutations in the 
39-kD binding site was isolated and transferred to the eukaryotic expres- 
sion vector containing the chloramphenicol acetyl transferase (CAT) re- 
porter gene. The integrity of the final construct was checked by direct se- 
quencing before its utilization in transfection studies. 
Transient Transfection  and CAT Assay 
Transfections were  performed  by  the  calcium phosphate  precipitation 
methods (15)  using the previously characterized  oligodendrocytic cells 
N20.1 (46).  The salient feature of these cells is in their ability to produce 
MBP.  After transfection, cells were maintained at 39°C  to suppress ex- 
pression of SV-40 T-antigen, and after 3 h, cells were harvested and CAT 
assay was carried out by the method described previously (13). 
Northern Blot Analysis 
Total RNA from pCMV-pur ~ transfected cells was prepared by hot phe- 
nol method (2), and after DNase I digestion to remove the endogenous 
DNAs in the samples, equal amounts of total RNAs (20 p,g) from various 
samples were analyzed by Northern blot procedure (2) using cDNAs from 
mouse MBP (gift of Dr. Jeffrey Green, Frederick Research &  Develop- 
ment Center, Frederick, MD) and glyceraldehyde 3-phosphate dehydrog- 
enase (GAPDH) as probes. 
Results 
Nuclear Proteins from Mouse Brain Recognize 
Single-stranded MB  I DNA 
Results from our previous studies have led to the identifi- 
cation of a nuclear protein from mouse brain that, upon in- 
teraction with the MB1 regulatory sequence of MBP, stim- 
ulates transcription of MBP promoter in an in vitro system 
(18). To better understand the requirements for interac- 
tion  of  the  MBl-binding  protein  to  its  target  DNAs, 
mouse brain nuclear extract was probed with both double- 
and single-stranded MB1 oligonucleotides in a band-shift 
assay. As shown in Fig. 1, a major B-complex was detected 
with the double-stranded MB1 probe (A  and B, lane 1). 
As  described earlier, two  other minor bands,  A  and  C, 
were detected upon prolonged exposure of the autoradio- 
gram. The single-stranded noncoding MB1  probe bound 
to the nuclear proteins and formed complexes with similar 
electrophoretic mobilities as A, B, and C (Fig. 1 A, lane 2). 
The coding strand of the MB1 showed an intermediate 
binding ability to the nuclear proteins (Fig. 1 B, lane 2). 
Competition  analysis  demonstrated  that  the  participant 
nuclear proteins bound more tightly to the single-stranded 
than to the double-stranded MB1 element, since the sin- 
gle-stranded DNA-protein complexes could be effectively 
competed  with  homologous  single-stranded  DNAs,  but 
not as efficiently with double-stranded MB1 DNA (Fig. 1 
A,  compare lanes 3  and 4 with 7 and 8  and B, compare 
lanes 3  and 4 with 5  and 6). Addition of single-stranded 
competitor that was complementary to the probe DNA re- 
sulted  in  reconstitution of double-stranded  probe  DNA 
and abolishment of the complexes (Fig. 1 A, lanes 5 and 6 
and B, lanes 7 and 8). Binding of the nuclear proteins to 
the noncoding strand of the MB1 element is in a sequence- 
specific manner, since the activity could be competed with 
homologous noncoding MB1 DNA, but not with an unre- 
lated, single-stranded oligonucleotide (Fig. 1 A, compare 
lanes 7 and 8 with 9 and 10). Conversely, binding to the 
coding strand appeared nonspecific, since equivalent com- 
petition was observed with the homologous coding strand 
DNA  and  an  unrelated  competitor  (Fig.  1  B,  compare 
lanes 5 and 6 with 9 and 10). 
In spite of their similar electrophoretic mobilities in the 
band-shift assay (shown in Fig, 1, A and B, lanes 1 and 2), 
one  could  argue  that  the  single-stranded  and  double- 
stranded  MBl-binding  proteins  may  not  be  identical. 
However, further competition studies  indicated that the 
formation of the A, B, and C complex requires the same 
sequence specificity for the single-stranded DNA as was 
previously  described  for  the  developmentally regulated 
nuclear proteins in an assay using double-stranded MB1 
probe DNA  (18), supporting the notion that the partici- 
pant single- and double-stranded proteins are identical. As 
shown in Fig. 1 D, the three complexes binding to the MB1 
noncoding strand  (Fig.  1 C, bottom strand) can be  effi- 
ciently  competed  with  noncoding  strands  from  MB1, 
MBIA, less efficiently with MBIA*, but not with MB1E 
competitors.  These  observations  demonstrate  that  the 
binding of the nuclear proteins to MB1 DNA is sequence 
specific, and has the target nucleotides within the MBIA 
oligonucleotide and that binding can be affected, at least 
partially, by three point mutations present in the MB1A*. 
Purification  of the Brain-derived MB  l-binding Protein 
The purification procedure for the  MBl-associated pro- 
teins compromised a combination of phosphocellulose and 
DNA  affinity  chromatography.  For  preparation  of  the 
starting  material,  brains  were  collected from mice  aged 
18-60 d and protein extracts were prepared by the proce- 
dure described previously (1). Nuclear proteins (5 mg/ml 
bed volume) were applied to phosphocellulose resin in 50 
mM KC1, and the column was eluted by a linear gradient 
of 100-700 mM KC1. Throughout the fractionation proce- 
dure, the activity was followed by using quantitative band- 
shift  assay  with  MB1  single-stranded  noncoding  MB1 
probe. The peak of the specific DNA-binding activity that 
assembled  in  the  B-complex was  eluted at  350-500 mM 
KCI (Fig. 2 A, lanes 13-18). This chromatographic step re- 
sulted in fourfold purification of the MBl-associated com- 
plex (shown in Table I), and separation of these proteins 
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In addition  to the fourfold enhancement of specific activ- 
ity, phosphocellulose chromatography also removed lipids 
and  fine  particles  from  the  extract.  Purification  of  the 
MBl-associated  proteins  to homogeneity was performed 
using DNA affinity chromatography. Toward this end, an 
oligonucleotide corresponding to the noncoding strand of 
the  MB1  was covalently linked  to sepharose  beads.  The 
active  protein  fractions  from  phosphocellulose  were 
pooled and applied to the affinity column, and eluted with 
buffer containing 0.15, 0.5, and 1.0 M  KC1. All three com- 
plexes,  A, B, and C, were eluted  in the 0.5 M  KC1 wash, 
however, a small amount of the slowest migrating complex 
(C-complex) was retained at 0.5 M KCI and eluted at 1.0 M 
KC1 (Fig. 2 B). Two rounds of affinity chromatography led 
to  210-fold purification  of the  phosphocellulose  fraction 
and 842-fold purification relative to nuclear extract (Table 
I). Through this procedure,  1,094 pmol (~44  txg)  of puri- 
fied MBl-binding  protein  was obtained  that  corresponds 
to a  9%  total yield (Table  I). The highly purified protein 
samples  were  visualized  with  apparent  molecular masses 
of 37, 39, and 42 kD (Fig. 2 C). 
For amino acid analysis, the more abundant protein, the 
39-kD species, was digested with trypsin and the cleavage 
products were isolated by HPLC. Two peptides  were se- 
quenced  and  the  results  indicated  a  perfect  match  with 
predicted amino acid sequence of human pur a  gene (Fig. 
3). The Pur c~ is a sequence-specific single-stranded DNA- 
binding protein that has a high affinity for the purine-rich 
motif (GGN)n  (3, 4).  The pur  c~ sequence predicts a  pro- 
tein of 322 amino acids in size, which is in good agreement 
with the 39-kD apparent molecular mass of the MBl-bind- 
ing protein, indicating that the purified 39-kD MBl-bind- 
ing protein is likely the mouse homologue of human Pur a. 
More recently, sequence  analysis of mouse Pur c~ protein 
indicated  extraordinary  high  sequence  conservation  be- 
tween  mouse  and  human pur  ce genes  (27).  In fact,  only 
two  amino  acid  alterations  between  the  human  protein 
Figure  1.  Single-stranded 
DNA-binding activity of the 
MBl-binding protein MEF-1. 
(A)  Binding  to  the  noncod- 
ing  strand  of the  MB1  ele- 
ment.  Band  shift  analysis 
using  end-labeled  double- 
stranded  (lane  1)  or single- 
stranded  noncoding  strand 
(lanes  2-10)  MB1  DNA  in 
the presence of 10 Ixg mouse 
brain  nuclear  extract.  For 
competition  analysis,  bind- 
ing reactions were incubated 
with competitor DNA before 
the  addition  of  probe. 
Competitors  were  double- 
stranded MB1  DNA (lane 3, 
10 ~g; lane 4, 50 ~g), single- 
stranded coding strand  MB1 
DNA (lane 5,  10 Ixg; lane 6, 
50  ~g),  single-stranded  non- 
coding  strand  MB1  DNA 
(lane  7,  10  I~g; lane  8,  50 
txg),  and  unrelated  single- 
stranded DNA derived from 
the CAT gene coding region 
(lane  9,  10  l~g; lane  10,  50 
I~g). A, B, and C indicate the 
complexes  corresponding  to 
the  MBl-binding  protein 
MEF-1,  and  P  indicates  the 
position  of  unbound  single- 
and  double-stranded  MB1 
DNA probe.  (B) Binding to 
the coding strand of the MB1 
element.  Identical to A  with 
the exception that the single-stranded probe DNA (lanes 2-10) is derived from the coding strand of the MB1 DNA. (C) Sequence struc- 
ture of MB1 and its sub-regions that were used in these studies.  (D) Sequence specific binding of MEF-1 to single-stranded DNA corre- 
sponding to the noncoding strand of the MB1 element. Band shift  analysis  using end-labeled single-stranded noncoding strand MB1 
DNA in the presence of 10 i~g mouse brain nuclear extract.  For competition analysis, binding reactions were incubated with competitor 
DNA before the addition of probe. All competitors were single-stranded DNAs derived from the noncoding strand of the MB1  ele- 
ment. Competitors were MB1 (lane 2, 10 txg; lane 3, 100 Ixg), MBIA (lane 4, 10 Ixg;  lane 5, 100 Ixg) MBldlA (lane 6, 10 txg; lane 7, 100 
~zg), MBldlE (lane 8, 10 Ixg;  lane 9. 100 Ixg). The letters, A, B, and C, indicate the complexes corresponding to the developmentally reg- 
ulated MBl-binding protein MEF-I (18) and the P indicates the position of unbound probe DNA. 
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of MBl-binding protein by phosphocellulose chromatography of 
mouse brain nuclear extract. Phosphocellulose chromatography 
was performed as described in the text, with the sample loaded in 
a buffer containing 100 mM KC1 and eluted with a linear salt gra- 
dient of the same buffer containing 100-800  mM KC1. Fractions 
(1-1xl aliquots)  were  analyzed  by  band  shift  assay  using  end- 
labeled single-stranded noncoding strand MB1 DNA (1-5 x  105 
cpm) as a probe. An outline of the chromatographic procedure 
and the corresponding fraction numbers are shown above the gel. 
The letters, A, B, and C, indicate the complexes corresponding to 
the developmentally regulated MBl-binding protein MEF-1 (18), 
which appear to coelute as a broad peak between 350-500 mM 
KC1. Faster  migrating complexes are  also seen, which elute  at 
200-300 mM KC1. (B)  Purification of MBl-binding protein by 
DNA  affinity  chromatography.  DNA  affinity  chromatography 
was  performed  as  described  in  the  text,  with  pooled fractions 
from the phosphocellulose column loaded onto the MB1 (single- 
stranded, noncoding) affinity column in a buffer containing 150 
mM KC1. The column was eluted with a step gradient of 0.5 M 
and 1.0 M KC1 in the same buffer. Fractions (1-1xl aliquots) were 
analyzed by band shift assay,  using end-labeled single-stranded 
noncoding strand MB1 DNA (1-5 x  105 cpm) as probe. An out- 
line of the chromatographic procedure is shown above the gel, 
and the corresponding fraction numbers are shown below. The 
letters, A, B, and C, indicate the complexes corresponding to the 
developmentally  regulated  MBl-binding  protein,  MEF-1  (18), 
which appear to coelute with 0.5 M KCI. The complex with the 
slowest  mobility seems to have a higher affinity for the column 
than the others, with a portion of this protein eluting only at the 
highest salt  concentrations (1.0 M).  (C) SDS-PAGE analysis  of 
the purified fractions.  Nuclear extract, 20 Ixg (lane 1), phospho- 
cellulose fraction, 7  Ixg (lane 2) and two times affinity purified 
and the mouse protein (321  amino acids) were identified. 
The  structural  organization  of Puret  revealed  three  re- 
peats of a  23-amino acid motif (class I) separated  by two 
repeats  of a  26-amino  acid motif (class  II). As shown in 
Fig. 3, the cleavage products of the MBl-associated 39-kD 
protein exhibited perfect identity to the regions from class 
I and class II. 
Binding of Pur ~  to MB1 Regulatory Motif 
To evaluate  the  ability  of Purct  to bind  to the  MB1  se- 
quence, the protein was produced in prokaryotic cells us- 
ing the pMAL-cR1 expression vector that permits synthe- 
sis of the protein  as  a  fusion to maltose-binding  protein. 
The binding ability of the Pur et fusion protein was investi- 
gated  by  band  shift  assay  utilizing  single-  and  double- 
stranded MB1 oligonucleotide probes. As shown in Fig. 4 
A, Pur a  showed strong binding activity to the noncoding 
strand of MB1 and exhibited a substantially reduced affin- 
ity to the coding strand  and the double-stranded MB1 re- 
gion (Fig. 4 A, compare lane 1 with lanes 3 and 4). The se- 
quence  specificity  of this  interaction  was  determined  by 
competition  analysis  with  unlabeled  oligonucleotides  de- 
rived  from  various  regions  of  the  noncoding  strand  of 
MB1.  Results  from these  studies  indicated  that the  unla- 
beled  competitor  corresponding  to  MB1A  effectively 
blocked  association  of Pur  et  with  the  probe  (Fig.  4  B, 
lanes  1-3).  Under  similar  conditions,  unrelated  single- 
stranded competitor exhibited no inhibitory action on the 
assembly of MB1/Pur a  complex (Fig. 4 B, lanes 4 and 5). 
These  data  demonstrate  that  prokaryotically  produced 
Purct binds to the noncoding strand of the MB1  element 
in a sequence-specific manner. 
Next, the DNA-binding activity of the cloned pur a gene 
product that is expressed by a  eukaryotic vector in oligo- 
dendrocytic cells was examined by band shift assay. In this 
study, N20.1 oligodendrocytic cells were transfected with a 
recombinant pur a  expression plasmid, pCMV-pur a, and 
after 48 h  nuclear extracts were prepared and used in the 
binding assays containing single- or double-stranded MB1 
DNA probes. Results shown in Fig. 5 A  indicated that the 
eukaryotically  produced  Pur  a  prefers  the  noncoding 
strand of MB1 rather than the coding strand and the dou- 
ble-stranded DNAs. Fig. 5 B  illustrates  results from band 
shift analysis of nuclear extract from untransfected N20.1 
cells  with  MB1  DNA  probe.  From  the  intensity  of the 
band (shown in lane 2) it appears that N20.1 cells produce 
significantly low levels of Pur a. Results from competition 
studies of nuclear extracts from cells overproducing Pur c~ 
(upon transfection  of pCMV-Pur  c  0  (Fig.  5  C)  indicated 
that binding of Puret produced by the transgene in oligo- 
dendrocytes to the MB1 DNA exhibits a similar sequence 
MEF-1, ~0.5  ~xg as estimated  by quantitative  band shift  assay 
(lane 3) were analyzed by SDS-PAGE and proteins were visual- 
ized by silver staining.  Three bands, of 42, 39, and 37 kD apparent 
molecular mass are observed in the affinity-purified MEF-1 prep- 
aration.  In  other  preparations,  only the  39-  and  37-kD  bands 
were reproducibly observed, while the presence of the 42-kD spe- 
cies was variable. 
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Strand) DNA Affinity 
Total protein  Total activity  Specific activity*  Fold purification  Total yield 
mg  u  u/mg  % 
NE  482  *  1.t8 x  104  24  1  100 
Pll  52  ¢  5.38 x  103  104  4  46 
1st affinity  1.0  1.28 x  103  1.28 x  103  53  11 
2nd affinity  55 X 10  -3§  1.09 x  103  2.19 x  103  842  9 
* One unit of bonding activity is defined as the amount of protein that will bind one pmol of radiolabeled oligonucleotide in the quantitative band shift assay. 
*Total protein on the basis of Bradford assay. 
~Total protein is estimated by SDS-PAGE and silver staining, by comparison with known quantities of marker proteins. 
specificity to that observed for the 39-kD protein shown in 
Fig. 1. Of note is that our binding results indicate that nu- 
cleotides at juxtaposition of GGC of the MB1 play an im- 
portant role in binding of Pur c~ to DNA since alterations 
of these nucleotides in the MB1A* decrease Pur c~ binding 
to MB1  sequence.  Thus, based on the molecular mass of 
the  purified  protein,  amino  acid  data,  and  the  require- 
ments for binding to the DNA, we concluded that the 39- 
kD  MBl-binding  protein  is  closely related  to the cloned 
pur a gene product. 
Fur a  Stimulates Transcription of the MBP Gene 
in Oligodendrocytes 
The capacity of the 39-kD Pur a  to modulate transcription 
of the  MBP gene  was evaluated  by cotransient  transfec- 
tion of N20.1 oligodendrocytes with the reporter p86-CAT 
and pCMV-pur a. The p86-CAT contains 86 bp upstream 
of the MBP transcription start site to +21 bp, downstream 
cloned at 5' position of the reporter CAT gene. As shown 
in  Fig.  6 A,  the  basal  transcriptional  activity of the  p86- 
CAT was increased in cells expressing moderate levels of 
Pur ct (compare lane 1 to lanes 2  and 3). At higher levels, 
however, Pur a  showed adverse effect, most likely due to 
the previously described squelching effect. Inclusion of the 
expresser plasmid containing pur a in the antisense orien- 
tation showed no significant effect on MBP gene transcrip- 
tion (Fig. 6 A, lanes 6-9). The activation of MBP promoter 
by Pur  a,  requires  the  intact  binding  site  for the  39-kD 
protein in the MB1A region, since alteration of 5'-GCCT- 
GTC-3'  to 5'-GCTCGAC-3' as  shown  in MB1A*  in  the 
reporter p86mut-CAT results in the loss of its responsive- 
ness to Fur ~  (Fig. 6 B). Again, antisense pur a showed no 
detectable  effect on the transcriptional activity of the mu- 
tant promoter (Fig. 6 B, lanes 6-9). As shown in Fig. 6 C, 
optimum concentration of Pur a  increases transcription of 
the MBP promoter and that this induction requires intact 
Pur c~ binding site within the MB1A promoter element. 
The  effect  of Pur  c~  on  expression  of the  endogenous 
MBP gene was assessed by Northern blot analysis of RNA 
derived from N20.1 cells and cells transfected with the pur 
a  expresser plasmid. As shown in Fig. 7, transient expres- 
sion of pur a  in this  oligodendrocytic cell line resulted  in 
elevated levels of MBP RNA in the cells (Fig. 7 A). Under 
similar conditions, the level of control GAPDH  RNA re- 
mained constant  (Fig. 7 B) and served as the baseline  for 
the quantitative analysis shown in Fig. 7 C. Thus, the effect 
of Put a  on MBP promoter activity is not limited to exoge- 
nously and transiently  expressed  messages.  Rather by af- 
fecting endogenous MBP promoter activity, Put a  appears 
to  increase  transcription  of  MBP  gene  in  oligodendro- 
cytes. 
Discussion 
The myelin sheath is a specialized plasma membrane struc- 
ture  generated  by the  myelin-forming cells,  oligodendro- 
cytes in the central nervous system, and Schwann cells in 
the peripheral nervous system. Oligodendrocytes are small 
cells with many processes that in white matter of the brain 
participate in myelination and in gray matter surround the 
cell bodies of neurons. A  single oligodendrocyte forms my- 
elin sheath around many axons by wrapping its plasma mem- 
brane around the axons. The initiation and maintenance of 
myelin sheath formation follows a complex regulatory pro- 
gram that is tightly controlled  during brain development. 
Figure 3.  Structural organization of the 39-kD Put a protein. Peptide sequences from a HPLC fraction that contains 39-kD MBl-bind- 
ing protein. The peptide sequences were compared with Pur a (4). Sequence identity of the primary structure of the 39-kD-derived pep- 
tides and the regions within class I (residues 73-78) and class II (residues 111-128) of Pur ~ are shown. 
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quence.  (A) 5'-end-labeled single-stranded  and duplex  oligonu- 
cleotides from MB1 region were analyzed for their ability to form 
complexes with maltose-binding  protein (MalBP) fused to Pur a. 
Lanes I and 2 present binding of the single-stranded  probes from 
noncoding  and coding strands  of MB1, respectively,  to the puri- 
fied fusion protein, whereas, lane 3 shows binding of the double- 
stranded MB1 to the MalBP-Pur a. The arrow shows the position 
of the complex and the P depicts  the position  of the unbound 
probe. (B) Specificity of the Pur a binding to the noncoding MB1 
sequence was tested by preincubation of the MalBP-Pur ~x fusion 
protein with 10 and 100 ng of noncoding strand of MB1A (lanes 2 
and 3), and 10 and 100 ng of an unrelated single-stranded  DNA 
(lanes 4 and 5). The arrow and P show the positions  of the com- 
plex and the free probe, respectively. 
Expression  of the  proteins  that  comprise myelin sheath, 
including  MBP  perfectly overlaps with  the  programmed 
production of myelin sheath. The MBP control region that 
regulates the rate of MBP gene transcription during brain 
Figure 5.  Binding of eukaryotically produced Pur c~ to MB1 se- 
quence.  (A) Oligodendrocytic  cell line N20.1 (46) maintained at 
39°C was transfected with pCMV-pur a (30 ~g per 100-mm dish) 
and after 4811 nuclear extracts were prepared and used in binding 
assays using single-stranded  (lanes 1 and 2) and double-stranded 
(lane  3)  MB1  oligonucleotides.  (B) Nuclear extracts from un- 
transfected N20.1 cells were incubated with MB1A probe and the 
resulting  nucleoprotein  complexes  were  resolved  by  native 
PAGE. The arrow indicates  association  of endogenous nuclear 
protein (Pur c~) with the probe. (C) Competition experiments us- 
ing  10, 50,  and  100 ng of the competitors from the noncoding 
strand of MB1A (lanes 2-4), MB1A* (lanes 5-7), and 50 and 100 
development  contains  multiple  cis-acting  elements  that 
are responsible for its unique pattern of expression.  It is 
postulated that similar to the  other eukaryotic genes, in- 
terplay between the cis-acting  elements of MBP genome 
and the regulatory proteins that are produced in the oligo- 
dendrocytes  balances  the  level of transcription  of MBP 
during myelinogenesis. It is also conceivable to speculate 
that the tight regulation of the MBP gene transcription is 
mediated by a combination of positive and negative regu- 
latory mechanisms. In an earlier effort to identify the regu- 
latory proteins that mediate developmental expression of 
MBP  by binding  to  these  regulatory  sequences,  we  em- 
ployed Southwestern blot and identified a sub-region within 
the MB1 proximal element of MBP called MB1A (nucle- 
otides  -14  to  -37)  that  binds  to 39  and  37-kD  protein 
components in young adult brain cells (26). Through par- 
tial purification and in vitro transcription studies, we dem- 
onstrated that the MB1A-associated protein has the abil- 
ity to  increase  transcription  of the  MBP  promoter  (18). 
Here we extended  those  observations and  by using con- 
ventional and DNA  affinity chromatography, we have pu- 
rified a 39-kD DNA-binding protein that upon interaction 
with the specific sequences within the MB1 regulatory ele- 
ment up-modulates transcription of the MBP promoter in 
oligodendrocytes.  This  is  an  interesting  observation  in 
light of the recent discovery of a repressor protein, MyEF- 
2,  which  by binding  to  the  MB1  sequence  that  partially 
overlaps with the 39-kD protein binding site, down-regu- 
lates MBP promoter activities. Of interest, unlike the 39- 
kD activator protein, which is more abundant only in brain 
during and after the period of active myelination (18), the 
suppressor MyEF-2 is produced in all mouse tissues,  and 
efficiently reduces the MBP promoter activity in nonoligo- 
dendrocytic context  (17,  41).  These observations suggest 
that the MB1 element may function not only to stimulate 
brain-specific transcription, perhaps by binding to the acti- 
vators such as Pur a, but could also restrict transcription of 
the MBP gene in other cells by interacting with repressors, 
including MyEF-2. Thus, programmed expression of MBP 
via MB1  domain may be accomplished by complex inter- 
play  of  the  activator(s)  and  suppressor(s).  Perhaps  it 
should  be  noted  that  several  DNA-binding  proteins  in- 
cluding  SCIP (30),  CTF-NF1  (21),  and  thyroid  hormone 
receptor transcription factor (11) have been shown to reg- 
ulate transcription  of the MBP promoter. It is also likely 
that  interaction  of Put  c~ and  other  transcription  factors 
become  important  parameters  in  the  overall  transcrip- 
tional  regulation  of  MBP  genome  in  oligodendrocytes. 
The availability of the cDNA clones for the participant ac- 
tivators  including,  Pur  c~,  and  the  suppressor,  MyEF-2, 
(41)  and  SCIP  should  enable  us  to  design  mechanistic 
studies that include parallel structural and functional anal- 
ysis of MBP gene expression by these regulatory proteins 
in  oligodendrocytic  cells.  Examination  of  the  effect  of 
these regulatory proteins on transcription of other myelin- 
ng of unrelated single-stranded DNA  (lanes 8-9).  The  arrow 
shows the position of the complex and P indicates the position of 
the unbound  probe. The sequence of the oligonucleotide compet- 
itors and the single-stranded  noncoding  strand of MB1 are shown 
in Fig. 1 C. 
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godendrocytic cells.  5  x  105  cells were  transfected  with  10  Ixg 
(lane 2) and 30 Ixg (lane 3) of pCMV-pur c~, and after 48 h  total 
RNAs were isolated and  after DNase  I  treatment,  fractionated 
on formaldehyde gel, transferred to nitrocellulose and hybridized 
to  MBP cDNA (A) or GAPDH  (B)  probes.  Lane  1  illustrates 
RNAs from cells that were transfected with pCMV vector with- 
out the pur c~ gene. (C) The intensity of the bands corresponding 
to MBP in the control and Pur c~ producing cells was normalized 
to GAPDH and rated on an arbitrary scale of 0 to 2.0 adsorption 
unit (ADU). 
C. 
d 
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Figure 6.  Activation of MBP promoter by Pur a  in oligodendro- 
cytic cells. Transient  cotransfection  analysis  of Pur a  transcrip- 
tional activity on wild type MBP promoter containing -86 to +21 
of the MBP sequence at 5' of the reporter CAT gene (A) or on its 
mutant  variant  that  contained  no binding  site for Pur  a  at  the 
MB1 region (B). 2.5 Ixg of the reporter plasmids were introduced 
into N20.1  cells alone (lane 1) or together with 0.5, 2.5,  5.0,  and 
10.0  ixg of pCMV-pur  e~  expresser plasmid  (lanes 2-5),  or with 
equal amounts of the pCMV construct containing pur eL in the an- 
tisense  orientation  by  the  Ca-phosphate  precipitation  method 
(15). After 48 h, extracts were prepared and CAT enzymatic ac- 
tivity was  determined  (13).  C  illustrates results of these studies 
that examine the effect of put ~, the antisense pur e~, on transcrip- 
tion of the wild type and mutant MBP promoters. Quantitation of 
the CAT assays represent an average of multiple experiments. 
associated genes including proteolipid protein  (PLP),  my- 
elin-associated  glycoprotein  (MAG),  etc.  is  also  of great 
significance. Here we have reported identification of a sin- 
gle-stranded DNA-binding  protein, Pur c~, which by bind- 
ing to its  target  sequence  enriched  in purine,  potentiates 
transcription  of MBP  promoter.  It appears  that Pur c~ be- 
longs to a  growing family of single-stranded DNA-binding 
proteins  that exhibit a  distinct affinity to the structure  and 
nucleotide composition of the DNA.  Recent observations 
in our  laboratory  identified proteins  with the  capacity  to 
bind single-stranded  DNA  that  modulate  transcription  of 
the JC virus promoter  (42).  In  addition,  two well-charac- 
terized transcriptional factors, the myogenic determination 
factor,  MyoD  (38)  and  the  estrogen  receptor  have  been 
shown  to bind  single-stranded  DNA  (25,  32).  At present, 
the biological significance of Pur a  binding to the noncod- 
ing strand of the MB1 motif remains unclear.  It is possible 
that  Pur  e~, by  binding  to  the  single-stranded  DNA,  in- 
duces DNA  binding and  thus facilitates interaction  of the 
upstream  activators  and  the  basal  transcriptional  com- 
plexes  assembled  at  the  initiation  site  of MBP  transcrip- 
tion. This hypothesis  is supported  by the notion that  sev- 
eral DNA-binding  proteins,  which stimulate  transcription 
of eukaryotic promoters, have a  unique ability for binding 
DNA  molecules (16,  19, 37, 39, 40).  Experiments  are cur- 
rently in progress in our laboratory to investigate the bio- 
logical significance  of Puret  binding  to  the  DNA  at  the 
level of  transcription,  DNA  replication,  and  recombina- 
tion. 
We wish to thank members of the Molecular Neurovirology Section of the 
Jefferson  Institute  of Molecular  Medicine for sharing their ideas and re- 
agents. We also express our special thanks to Dr. P. Zoltick, for his techni- 
cal advice and  assistance  in constructing  some of the plasmids when he 
was working in our laboratory.  We would also like to thank J. Gordon for 
critical reading of this manuscript and C. Schriver for its preparation. 
This work was made possible by grants awarded  by the National  Insti- 
tutes of Health to K. Khalili and S. Amini. 
Received for publication  10 February  1995 and  in revised  form 18 May 
1995. 
References 
1. Ahmed, S., J. Rappaport, H. Tada, D. Kerr, and K. Khalili. 1990. A nuclear 
protein derived from brain cells stimulates transcription of the human 
neurotropic virus  promoter, JCV  E  in vitro.  J. Biol. Chem. 265:13899-13905. 
2. Ausubel, F., R. Brent, R. Kingston, D. Moore, J. G. Seidman, J. A. Smith, 
and K. Struhl. 1989. Current Protocols in Molecular Biology,  John Wiley 
and Sons, New York. 
3. Bergemann, A. D., and E. M. Johnson. 1992. The Hela Pur factor binds sin- 
gle-stranded DNA at a specific element conserved in gene flanking re- 
gions and origins  of DNA replication. MoL Cell. Biol. 12: I257-1265. 
4. Bergemann, A. D., Z. W. Ma, and E. M. Johnson. 1992. Sequence of cDNA 
comprising the human pur gene and sequence-specific  single-stranded- 
DNA-binding properties of the  encoded protein. Mol. Cell. Biol. 12: 
5673-5682. 
5. Campagnoni, A. T. 1988. Molecular biology of myelin proteins from the 
central nervous system.  J. Neurochem. 51:1-14. 
The Journal of Cell Biology, Volume 130, 1995  1178 6.  Campagnoni, A. T., and W. B. Macklin. 1988. Cellular and molecular as- 
pects of myelin protein gene expression. Mol. Neurobiol. 2:41-89. 
7. deFerra, F., H. Engh, L. Hudson, J.  Kamholz, C. Puckett, S. Molineaux, 
and R.A.  Lazzarrini.  1985.  Alternative splicing accounts for  the  four 
forms of myelin basic protein. Cell. 43:721-727. 
8. Devine-Beach, K. A., M. S. Lashgari, and K, Khalili. 1990.  Myelin basic 
protein gene transcription: identification of proximal and distal cis-acting 
regulatory elements. J. Biol. Chem. 265:13830-13835. 
9.  Devine-Beach, K. A., S. Haas, and K. Khalili. 1992. Analysis of the proxi- 
mal transcriptional element of the myelin basic protein gene. Nucleic Ac- 
ids Res. 20:545-550. 
10. Dubois-Dalcq, M., T. Behar, L. Hudson, and R. A. Lazzarini. 1986. Emer- 
gence of three myelin proteins in oligodendrocytes cultured without neu- 
rons. J. Cell Biol. 102:384-392. 
11. Farseffi, A., T. Mitsuhashi, B. Desvergne, J. Robbins, and V. M. Nikodem. 
1991. Molecular basis of thyroid hormone regulation of myelin basic pro- 
tein gene expression in rodent brain. Z  BioL Chem. 266:23226-23232. 
12. Foran, D. R., and A. C. Peterson.  1992. Myelin acquisition in the central 
nervous system of the mouse revealed by an MBP LacZ transgene. J. 
Neurosci. 12:4890--4897. 
13. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant ge- 
homes express chloramphenicol acetyl transferase in mammalian cells. 
Mol. Cell.  BioL 2:1044-1051. 
14. Cow, A., V. L. Friedrich, and R. A. Lazzarini. 1992. Myelin basic protein 
gene contains separate enhancers for oligodendrocyte and Schwann cell 
expressiom J. Cell Biol. 119:605~516. 
15.  Graham, F. L., and A. J. van der Eh.  1973. Transformation of rat cells by 
human adenovirus 5. Virology. 52:456~67. 
16. Gustafson, T. A., A. Taylor, and L. Kedes. 1989. DNA bending is induced 
by a transcriptional factor that interacts with the human c-los and alpha- 
actin promoters. Proc. Natl. Acad. Sci.  USA. 86:2162-2166. 
17. Haas  S.,  J.  Gordon,  and K.  Khalili. 1993.  A  developmentally regulated 
DNA-binding protein from mouse brain stimulates myelin basic protein 
gene expression. MoL CelL Biol. 13:3103-3112. 
18. Haas, S.,  A. Steplewski, L. D.  Siracnsa, S.  Amini, and K.  Khalili. 1995. 
Identification of a sequence-specific single-stranded DNA binding pro- 
tein that suppresses transcription of the mouse myelin basic protein gene. 
J. Biol. Chem. 270:12503-12510. 
19. Horikoshi, M., C. Bertuccioli, R. Takada, J. Wang, T. Yamamoto, and R. G. 
Roeder.  1992. Transcription factor TFIID induces DNA bending upon 
binding to the TATA element. Proc. Natl. Acad. Sci.  USA. 89:1060-1064. 
20.  Inostroza, J. A., F. H. Mermelstein, L Ha, W. S. Lane, and D. Reinberg. 
1992. Drl, a TATA-binding protein-associated phosphoprotein and in- 
hibitor of class ll gene transcription. Cell. 70:477-489. 
21.  Inoue, T, T. Tamura, T.  Furuichi, and K. Mikoshiba. 1990.  Isolation of 
complementary DNAs encoding a cerebellum-enriched nuclear factor I 
family that activates transcription from the mouse myelin basic protein 
promoter. J. Biol. Chem. 265:19065-19070. 
22. Kadonaga, J. T., and R. Tjian. 1986. Affinity purification of sequence-spe- 
cific DNA binding proteins. Proc. Natl. Acad. Sci. USA. 83: 588%5893. 
23.  Kamholz, J., F. deFerra, C. Puckett, and R. A. Lazzarini. 1986. Identifica- 
tion of three forms of human  myelin basic protein by cDNA cloning. 
Proe. Natl. Acad. Sci. USA. 83:4962-4966. 
24. Kimura, M., M. Sato, A. Akatsuka, S. Nozawa-Kimura, R. Takahashi, M. 
Yokoyama, T. Nomura, and M. Katsuki. 1989. Restoration of myelin for- 
mation by a  single type of myelin basic protein in transgenic shiverer 
mice. Proc. Natl. Acad. Sci.  USA. 86:5661-5665. 
25.  Lannigan, D. A., and A. C. Nitodes.  1989.  Estrogen receptor selectively 
binds the "coding strand" of an estrogen responsive element. Proc. Natl. 
Acad. Sci.  USA. 86:863-867. 
26. Lashgari, M. S., K. A. Devine-Beach, S. Haas, and K. Khalili. 1990. Nuclear 
proteins in mouse brain ceils bind specifically to the myelin basic protein 
regulatory region. J. Clin. Invest. 86:1671-1677. 
27.  Ma, Z.-W., A. D.  Bergemann, and E. M. Johnson.  1994. Conservation in 
human and mouse Pur a  of a motif common to several proteins involved 
in initiation of DNA replication. Gene (Amst.). 149:311-314. 
28.  Miskimins, R., L. Knapp, M. J. Dewey, and X. Zhang. 1992. Cell and tissue- 
specific expression of a  heterologous gene under control of the myelin 
basic protein gene promoter in transgenic mice. Dev. Brain. Res. 65:217- 
221. 
29.  Miura, M., T. Tamura, A. Aoyama, and K. Mikoshiba. 1989. The promoter 
elements of the mouse myelin basic protein gene function efficiently in 
NG108-15 neuronal/glial cells. Gene (Amst.). 75:31-38. 
30.  Monuki, E. S., R. Kuhn, G. Weinmaster, B. Trapp, and G. Lemke. 1990. 
Expression and activity of the POU  transcription factor SCIP. Science 
(Wash. DC). 249:1300-1303. 
31. Morell, P., R. H. Quarles, and W. T. Norton. 1989. In Basic Neurochemistry: 
Molecular, Cellular, and Medical Aspects Fourth ed. G. J. Siegel, R. W. 
Alberts, B. W. Agranoff, and R. Katzman, editors. Raven Press, NY. 109- 
136. 
32. Mukherjee,  R.,  and P.  Chambon.  1990.  A  single-stranded DNA-binding 
protein promotes the binding of the purified estrogen receptor to its re- 
sponsive element. Nucleic Acids Res. 18:5713-5716. 
33. Newman, S. L, K. Kitamura, and A. T. Campagnoni. 1987a. Identification 
of a eDNA coding for a fifth form of myelin basic protein. Proc.  NatL 
Acad. Sci. USA. 84:886-890. 
34.  Readhead, C., B. Popko, N. Takahashi, H. Shine, R. Saavedra, R. Sidman, 
and L. Hood.  1987. Expression of a myelin basic protein gene in trans- 
genie shiverer mice: correction of the dysmyelinating  phenotype. Cell. 48: 
703-712. 
35.  Roth, H., K. Kronquist, P. J. Pretorius, B. F. Crandall, and A. T. Campa- 
gnoni. 1986. Isolation and characterization of a eDNA coding for a novel 
human  17.3k  myelin basic protein (MBP) variant. J.  Neurosci,  Res.  16: 
227-238. 
36,  Roth, H., K. Kronquist, N. Herlero de Rosbo, B. F.  Crandall, and A. T. 
Campagnoni. 1987. Evidence for the expression of four myelin basic pro- 
tein variants in the developing human spinal cord through cDNA clon- 
ing. J. Neurosci. Res. 17:321-328. 
37.  Ryder, K., S. Silver, A. L. DeLucia, E. Fanning, and P. Tegtmeyer. 1986. 
An altered DNA conformation in origin region I is a determinant for the 
binding of SV40 large T antigen. Cell. 44:719-725. 
38. Santoro,  I.  M.,  T.-M.  Yi, and  K.  Walsh.  1991.  Identification of single- 
stranded DNA-binding protein that interacts with muscle gene elements. 
MoL Cell.  Biol. 11:1944-1953. 
39.  Shuey, D. J., and C. S. Parker, 1986. Bending of promoter DNA on binding 
of heat shock transcription factor. Nature (Lond.). 323:459-461. 
40.  Spana, C., and V. G. Corces. 1990. DNA bending is a determinant of bind- 
ing specificity for a Drosophila zinc finger protein. Genes Dev. 4:1505- 
1515. 
41.  Steplewski, A.,  S.  Haas,  S.  Amini, and  K.  Khalili. 1994.  Regulation of 
mouse myelin basic protein gene transcription by a sequence-specific sin- 
gle-stranded DNA-binding protein in vitro. Gene (Amst.). 154:215-218. 
42. Tada, H., and K.  Khalili. 1992.  A  novel sequence-specific DNA-binding 
protein, LCP-1,  interacts with single-stranded DNA  and differentially 
regulates early gene expression of the human neurotropic JC virus, Z  Vi- 
rol. 66:6885~i892. 
43. Takahashi, N., A. Roach, D. B. Teplow, S. Prusiner, and L. E. Hood. 1985. 
Cloning and  characterization of  the  myelin basic protein  gene  from 
mouse: One gene can encode both the 14 kD and the 18.5 kD myelin ba- 
sic proteins by alternate use of exons. Cell. 42:139-148. 
44. Tamura, T., A. Aoyama, T. Inoue, M. Miura~ H. Okano, and K. Mikoshiba. 
1989. Tissue-specific in vitro transcription from the mouse myelin basic 
protein promoter. Mol. Cell.  Biol. 9:3122-3126. 
45. Tamura, T.,  K.  Sumita, and K.  Mikoshiba. 1991.  Sequences involved in 
brain specific in vitro transcription from the core promoter of the mouse 
myelin basic protein gene. Biochim. Biophys. Acta. 1129:83-86. 
46. Verity, A., D. Bredesen, C. Vonderscher, V. W. Handley, and A. T. Cam- 
pagnoni. 1993. Expression of myelin protein genes and other myelin com- 
ponents in a oligodendrocytic cell line conditionally immortalized with a 
temperature-sensitive retrovirus. Z Neurochem. 60:577-587. 
47.  Zeller, N. K., T. N. Behar, M. E. Dubois-Dalcq, and R. A. Lazzarini. 1985, 
The timely expression of myelin basic protein gene in cultured rat brain 
oligodendrocytes is independent  of  continuous  neuronal  influence. J. 
Neurosci. 5:2955-2962. 
Haas et al. Transcriptional Regulation of Myelin Basic Protein  1179 